United Kingdom· GB-APID-4892411000001103
Streptomycin 1g powder for solution for injection vials
A streptomycin product containing streptomycin, registered in United Kingdom by Focus Pharmaceuticals Ltd. The same ATC class is registered in 7 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Streptomycin is registered in 7 of 19 countries.
Countries holding a registration under ATC J01GA01 (streptomycin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 5 of them publish a price we can compare per daily dose
Streptomycin · ATC J01GA01
7 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Streptomycin
- Manufacturer
- Focus Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- J01GA01
- ATC class
- Streptomycin
- Defined daily dose
- 1 g, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5015313001656
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
199 interactions on record for streptomycin.
Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Streptomycin · interactions on record
199 records
- 50 severe
- 126 moderate
- 2 minor
- 21 info
Most severe, free to view
- Magnesium sulfateA06AD04severe
- MannitolA06AD16severe
- Polymyxin BA07AA05severe
- Magnesium sulfateA12CC02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Streptomycin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaSTREPTOMYCIN FOR INJECTION USPSTERIMAX INC
- CzechiaSULFATO DE ESTREPTOMICINA REIG JOFRÉ
- SpainSULFATO DE ESTREPTOMICINA REIG JOFRE 1 G POLVO PARA SOLUCIÓN INYECTABLELaboratorio Reig Jofre, S.A.
- NorwayStreptomycin x-genPharma-Tek
- PolandStreptomycinum TZFTarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- United StatesStreptomycinXGen Pharmaceuticals DJB, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Spain · Sulfato De Estreptomicina Reig Jofré
- Poland · Streptomycinum Tzf
- Portugal · Estreptomicina Labesfal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/28b4e3f0-05fd-496e-bc1b-2bcdc504f064 GET /v1/drugs/28b4e3f0-05fd-496e-bc1b-2bcdc504f064?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4892411000001103",
"desc": "Streptomycin 1g powder for solution for injection vials (Focus Pharmaceuticals Ltd)",
"form": "Powder for solution for injection",
"vpid": "41955211000001103",
"source": "dmd",
"vtm_id": "777614004",
"strength": "1 gram",
"substance": "Streptomycin",
"ingredient": "Streptomycin sulfate",
"supplier_code": "10309711000001100"
}See everything about streptomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.